Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

5056 - Nasopharyngeal cancer in children: Long term results The experience of the university hospital of Sfax (Tunisia)


10 Sep 2017


Poster display session


Cancers in Adolescents and Young Adults (AYA);  Head and Neck Cancers


Lilia Ghorbal


Annals of Oncology (2017) 28 (suppl_5): v372-v394. 10.1093/annonc/mdx374


L. Ghorbal1, N. Toumi2, H. Ben Salah1, S. Charfi3, A. Ghorbel4, A. Khanfir2, M. Frikha2, J. Daoud1

Author affiliations

  • 1 Radiation Oncology, Hopital Habib Bourguiba - Sfax University, 3029 - Sfax/TN
  • 2 Medical Oncology, Hopital Habib Bourguiba - Sfax University, 3029 - Sfax/TN
  • 3 Pathology, Hopital Habib Bourguiba - Sfax University, 3029 - Sfax/TN
  • 4 Orl, Hopital Habib Bourguiba - Sfax University, 3029 - Sfax/TN


Abstract 5056


Nasopharyngeal carcinoma in children is frequent in Mediterranean area. We aimed to report our experience in the treatment of this entity.


We retrospectively review the records of 76 young patients (


Mean age was 16 years (9 – 20). Sex-ratio was 1,1. Seventy two percent of patients (n = 55) had locally advanced tumor (T3 or T4). Cervical nodal involvement was seen in 95% of cases (n = 71). There were 52 cases (68%) of N2 or N3. Sixty-six patients had neoadjuvant chemotherapy, 10 had concomitant and 5 had both. Five patients had exclusive irradiation. Radiotherapy was monofractionated in 45 cases and bifractionated in the remaining cases. Acute toxicities were tolerable. Mean follow-up was 198 months (28- 289). One patient experienced a local failure. Twenty-six presented metastatic failures. Overall survival rate at 10 years is 67,4%. Disease free survival rate at 10 years is 66,7%. Xerostomia was the most frequent late toxicity (97%). Patients experienced endocrine troubles (hypothyroidism in 19%, amenorrhea in 13%), cerebral necrosis (5cases), osteoradionecrosis (10 cases) and secondary cancer (3 cases).


Pediatric nasopharyngeal carcinoma has good prognosis despite frequent locally advanced disease at presentation. Combining radiotherapy and chemotherapy is the standard of care. Late toxicities are often severe and affect the quality of life.

Clinical trial identification

Legal entity responsible for the study

University Hospital of Sfax - Tunisia




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.